Infection control measures in the intensiv-care-medicine. Efficacy of intranasal mupirocin in the prevention and therapy of an MRSA-outbreak;Infektionsmanagement in der Operativen Intensivmedizin: Bekampfung und Pravention von MRSA-Epidemien durch routinemassiges mikrobiologisches Monitoring und Einsatz von Mupirocin-Nasensalbe

Intensivmedizin und Notfallmedizin

Volumn 34, Issue 8, 1997, Pages 778-789

  Schweitzer, M ^a   Walther, Th ^b   Juraske, J ^b   Osswald, P M ^a  

^a Stadtkrankenhaus Hanau   (Germany)

^b Stadtkrankenhaus Hanau   (Germany)

Author keywords

Infection control measures; Methicillin resistant staphylococcus aureus; Mupirocin intranasal ointment

Indexed keywords

ANTIBIOTIC AGENT; GLYCOPEPTIDE; METICILLIN; PSEUDOMONIC ACID;

ADULT; AGED; ARTICLE; COST; DRUG EFFICACY; EPIDEMIC; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 0031463527     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050104     Document Type: Article

References (45)

1. Ayliffe GAJ, Cookson BD, Keane CT, Marples, RR, Phillips I, Shanson CD, Simmons NA, Williams JD, Duckworth GJ, Brumfitt W, Casewell MW, Cooke EM (1986) Guidelines for the control of epidemic MRSA. J Hosp Infect, pp 193-201
2. Bacon AE, Jorgensen KA, Wilson KH, Kauffman CA (1987) Emergence of nosocomilal methicillin-resistant Staph. aureus and therapy of colonized personnel during a hospital-wide outbreak. Infect Control 8: 145-150
3. Bendall RP, Gonzales-Ruiz A, Batiste L, Kelsey MC (1994) Outcome of MRSA carriage. Lancet 344: 819
4. Benner EJ, Kaiser GH (1968) Growing clinical significance of methicillin-resistant Staphylococcus aureus. Lancet. 1968/II, 741-744
5. Boelaert JR (1992) Prevention of Staphylococcus aureus bacteraemias in haemodialysis patients: cost effectiveness. In: Daschner F. Staphylokokken im Krankenhaus. Expertenmeeting in Freiburg am 4.4.1992. Universimed-Veriag
6. Boyce JM (1991) Methicillin-resistant Staphylococcus aureus in nursing homes: putting the problem in perspective. Infect Control Hosp Epidemiol 12: 413-415
7. Boyce JM (1989) MRSA: detection epidemiology, and control measures. Infect Dis Clin North Am 3: 901-913
8. Boyce JM (1981) Nosocomial staphylococcal infections. Ann Intern Med 95: 241-242
9. Boyce JM (1992) Methicillin-Resistant Staphylococcus aureus in Hospitals and Long-Term Care Facilities: Microbiology, Epidemiology, and Preventive Measures, Infect Control Hosp Epidemiol 13 725-737
10. Braunwarth H, Hanf V et al. (1995) Aktuelle Aspekte lokaler Desinfizientien in der Gynäkologie und Urologie. Int J Feto - Maternal Med 7: 5-58
11. Caputo GM, Singer M, White S, Weitekamp MR (1993) Infections due to Antibiotic-resistant Gram-positive Cocci. Journal of General Internal Medicine, Vol 8
12. Casewell MW, Hill RLR (1986) The carrier state: MRSA. J Antimicrob Chemother. 18 Suppl A: 1-12
13. Casewell MW (1992) Mupirocin nasal ointment for the control of epidemic MRSA-dosage requirements and resource implications. In: Daschner F. Staphylokokken im Krankenhaus. Expertenmeeting in Freiburg am 4.4.1992. Universimed-Verrag
14. Coella R, Caspar C, Femandez C, Arroyo P, Cruzet F (1992) The importance of detecting asymptomatic carriage and the use of nasal mupirocin for the control of MRSA. In: Proceedings of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy: Oct 11-14, Anaheim. Abstract no. 366: 172
15. Cookson BD (1990) Mupirocin resistance in staphylococci. J Antimicrob Chemother 25. 497-503
16. Crossley K, Landesman B, Zaske D (1979) An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoslycosides. J Infect Dis 139: 280-287
17. Daschner F (1992) Methoden zur Reduzierung von krankenhauserworbenen Staphylokokken-Infektionen. In: Daschner F. Staphylokokken im Krankenhaus. Expenenmeeting in Freiburg am 4.4.1992. Universimed-Verlag
18. Davies EA, Emmerson AM, Hogg GM, Patterson MF, Shields MD (1987) An outbreak of infection with a MRSA in a special care baby unit: value of topical Mupirocin and of traditional methods of infection control. J Hosp Infect 10: 120-128
19. Duckworth GJ (1993) Diagnosis and management of MRSA infection. BMJ 307: 1049-1052
20. Heuck D, Braulke C, Lauf H, Witte W (1995) Analysen und Schlußfolgerungen zur epidemischen Verbreitung von Methicillin-resistenten Staph. aureus. Zbl Hyg 198: 57-71
21. Hudson IRB (1994) The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect 27: 81-98
22. Jevons MP (1961) "Celbenin"-resistant staphylococci. BMJ 1: 124-125
23. Kappstein I (1992) Spezielle Isolierungs- und Therapiemaßnahmen bei Oxacillin-resistenten Staphylococcus aureus. In: Daschner F. Praktische Krankenhaushygiene und Umweltschutz. Springer-Verlag, Berlin Heidelberg
24. Kluytmans J, Maat A, Manders M, Wagenvoort J (1992) Reduction of postoperative wound infection by elimination of nasal carriage of Staphylococcus aureus. In: Proceedings of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Oct 11-14, Anaheim. Abstract no. 1267: 322
25. Martin MA (1994) Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. Current clinical topics in infectious diseases. 14: 170-191
26. Maki DG, McCormick RD, Zilz MA, Stolz SM, Alvarado CJ (1990) A MRSA outbreak in a SICU during universal precaution: new epidemiology for nosocomial MRSA: downside for universal precautions (abstract 473). 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. Atlanta
27. Muder RR, Brennen C, Wagener MM, Vickers RM, Rihs JD (1991) MRSA colonization and infection in a longterm care facility. Ann Intern Med 144: 107-112
28. Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, Kauffmann CA, Yu VL (1993) Methicillin-Resistant Staphylococcus aureus: A Consensus Review of the Microbiology, Pathogenesis and Epidemiology with Implications for Prevention and Management. Am J Med 94: 313-328
29. Myers JP, Linnemann CC (1982) Bacteraemia due to methicillin-resistant-staphylococcus aureus. J Infect Dis 145: 532-536
30. Patterson JE (1996) Making real sence of MRSA. Lancet 348: 836-837
31. Peacock JE, Moorman DR, Wenzel RP, Mandel GL (1981) MRSA. Microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain. J Infect Dis 144: 575-582
32. Prout J, Peters B, Greaves W, Frederick W (1991) Changing patterns of MRSA in an inner-city hospital, 1987-1990. In: Proceedings of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract no. 26: 103
33. Reagan D, Doebbeling B, Pfaller MA (1991) Elimination of coincident Staphylococcus aureus nasal and hand carnage with intranasal application of mupirocin calcium ointment. Ann Intern Med 114: 101-106
34. Report of a combined working party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy (1986) Guidelines for the control of epidemic MRSA. J Hosp Infect 7: 193-201
35. Reybrouck G, Borremans A (1995) Screening for Methicillin-Resistant Staphylococcus aureus in an Acute Care University Hospital. Hyg Med 20: 392-399
36. RKI (1996) Erste Resistenz gegen Mupirocin bei der Sanierung von MRSA-Trägern in Deutschland beobachtet. Epidemiologisches Bulletin 49: 337-338
37. Schmitz FJ, Geisel R, Wagner S, Lenz W, Idel H, Hadding U, Heinz HP (1996) Bildung von Enterotoxin und Toxic Shock-Syndrom-Toxin 1 bei Methicillin-resistenten und -sensiblen Staphylococcus-aureus-Stämmen. J Lab Med 20: 342-350
38. Staphylokokken-Alarm (1992) Expertendiskussion. Münch med mit Junge Praxis. 134:8-16
39. Thompson RL, Cabezudo I, Wenzel RP (1982) Epidemiology of nosocomial infections caused by MRSA. Ann Intern Med 97: 309-317
40. Ullmann U, Schaal KP, Pohle HD, Buckel P (1996) Memorandum-Aufklärungs- und Forschungsinitiative Antibiotikaresistenz. top medizin 10: 8
41. Voss A, Machka K, Lenz W, Milatovic D (1992) Vorkommen. Häufigkeit und Resistenzverhalten von Methicillin-Oxacillin-resistenten Staphylococcusaureus-Stämmen in Deutschland. DMW 117: 1907-1912
42. Walsh TJ, Vlahov D, Hansen SL (1987) Prospective microbiologic surveillance in control of nosocomial methicillin-resistant Staphylococcus aureus. Infect Control 8: 7-14
43. Wenzel RP, Nettleman MD, Jones RN, Pfaller MA (1991) MRSA: implications for the 1990s and effective control measures. Am J Med 91 Suppl 3B: 221S-227S
44. Witte W, Klare I, Fock R (1996) Chemotherapeutikaresistenz bei bakteriellen Infektionserregern und infektiöser Hospitalismus. In: Infektionsepidemiologische Forschung II: 1-13
45. Yu VL, Goetz A, Wagener M et al. (1986) Staphylococcus aureus nasal carrier infection in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med 315: 91-96